Form D · Pharmaceuticals
Cortria Corp
Boston, MA · CIK 0001400828
Offering snapshot reported Jul 10, 2009 · SEC filing
- Reported sold
- $1.84M Offering amount: $4.47M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 30, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 10, 2009 | Initial | $1,841,000 | No comparison | 6 | SEC filing |
| May 9, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-103587
Source: Form D, filed Jul 10, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jerzy Gebicki | Director |
| Daniel Grau | Director, Executive |
| Jay Hachigian | Executive |
| Brian Halak | Director |
| Richard King | Director |
| Stephen Reeders | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
C/O Mvm Life Sciences Partners Old City Hall, 45 School Street
Boston, MA, 02108
Boston, MA, 02108